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1. Introduction 
Breast cancer is the most common cancer in women worldwide, comprising 16% of all 
female cancers and is the leading cause of cancer-related deaths in women ages 40-55. Each 
year in the U.S.A. over 180,000 women are diagnosed with breast cancer and 46,000 women 
die of this disease. One in twelve women in the United Kingdom develops breast cancer and 
the annual death toll stands at around 14,000. Over 33,000 new cases are being monitored 
year on year basis in the UK. In all, 10%-11% of all women can expect to be affected by 
breast cancer at some time during their lives. The causes of most breast cancers are not yet 
fully understood. Sixty years ago, MacDonald proposed that the biological behaviour of a 
neoplasm is established during its preclinical growth phase (MacDonald, 1951). This view is 
supported by some data on the behaviour of metastatic lesions such as poor cytological 
differentiation, lymphatic permeation, blood vessel invasion and the invasion of the 
surrounding soft tissue by the tumour (Nealon et al, 1979). Screening and early diagnosis 
are currently the most effective ways to reduce mortality from this disease. Early diagnosis 
and treatment are the keys to surviving breast cancer. Breast cancer survival rates vary 
greatly worldwide, ranging from over 80% in North America, Sweden and Japan to around 
60% in middle-income countries and below 40% in low-income countries. It is believed that 
the low survival rates in less developed countries are mainly due to the lack of early 
detection programmes, resulting in a high proportion of women presenting with late-stage 
disease, as well as by the lack of adequate diagnosis and treatment facilities. Studies from 
the American National Cancer Institute show that 96 percent of women whose breast cancer 
is detected early live five or more years after treatment. Early diagnosis remains an 
important detection strategy, particularly in low- and middle-income countries where the 
disease is diagnosed in late stages and resources are very limited. There is some evidence 
that this strategy can produce "down staging" of the disease to stages that are more 
amenable to less aggressive treatment. Therefore, thousands of lives and considerable 
healthcare costs could be saved each year with treatment if early symptoms of breast cancer 
are detected. Taking full advantage of early diagnosis and treatment means that screening 
technology should have the characteristics that have high detection success rate, speed of 
procedure, comfort to the subject and very low health risk. 
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The principal aim of early breast cancer detection is to identify the disease at a more curable 
stage and thus improve the prognosis and other vital clinical outcomes. Currently breast 
cancer detection is a three part procedure. The first part is identification of the abnormality 
in the breast tissue either by physical examination or by an imaging technique. Secondly, the 
abnormality is diagnosed as a benign or a malignant condition by using additional 
diagnostic methods or by biopsy and microscopic examination of the tissue morphology. 
The third part is concerned with biochemical characterisation of the malignant tissue in 
order to stage the cancer according to the size of the tumour and extent of invasion and 
metastasis. Of particular importance is the ability to clearly distinguish between malignant 
and benign tumours and early detection. This then determines the prognosis and 
appropriate course of treatment. A review of the published literature shows that all current 
breast cancer detection techniques have limited capability and surgery is often required to 
establish the true nature of the tumour.  
Currently, the frontline strategies for breast cancer detection still depend essentially on 
clinical and self-examination and mammograms. The limitations of mammography, with its 
reported sensitivity rate often below 70% are recognized (Sickles, 1984) and the proposed 
value of self-breast examination is being queried (Thomas et al, 1997). Mammography is 
accepted as the most reliable and cost-effective imaging technique, however, its contribution 
continues to be challenged with persistent false-negative results - ranging up to 30% 
(Moskowitz, 1983 & Elmore et al, 1884). However, most of the research and development 
activity related to cancer detection and diagnosis is focussed on the analysis of the existing 
condition and is costly, time-consuming and requires trained personnel to use the 
equipment. Furthermore, the incidence of the earliest form of breast cancer, Ductal 
Carcinoma in Situ (DCIS), has increased significantly over the last few years in the United 
States and this seems to be directly related to successful screening programmes. This clearly 
shows that there is a need and scope for developing early breast cancer detection techniques 
that are simple, quick and can be used by women by themselves.  
In this chapter a review of some of the most promising techniques that are being developed 
for breast cancer detection is presented. A comparison of the various breast cancer detection 
techniques that are in the developmental stages with the established procedures has been 
carried out and a state-of-the-art in all the areas is briefly described and the concept of a 
wearable breast cancer detection device - the ‘smart bra’- is also discussed. Particular 
emphasis has been placed on the non-invasive thermometry based methodologies for early 
detection of the oncological condition. When infrared thermography was first introduced in 
medicine, the instrumentation was not sensitive enough to detect the subtle changes in 
temperature that are involved in diseases such as breast cancer. However, more recently the 
sensitivity of infrared instrumentation has greatly improved and the IR thermography 
imaging is being developed and used to monitor the health of the breast and detection of 
cancerous tumours. Recent literature shows that the technique has the ability to detect 
tumours that are 3cm in size and are located deeper than 7 cm from the skin surface and 
tumours smaller than 0.5 cm can be detected if they are close to the surface of the skin. Non-
invasive techniques based on profiling of the breast tissue using microwave radiometry are 
also being developed and investigated as early warning systems for breast cancer. These 
techniques involve the measurement of the passive electromagnetic thermal radiation 
emitted from human body using suitable combination of microwave antenna internal 
temperature sensor and infrared surface temperature sensor, with an appropriate 
configuration to determine the temperature profile of the concerned area of the body. 
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Microwave radiometry principles can be employed to obtain sensor information from 
subcutaneous tissues up to a few centimetres in depth. The device based on these principles 
can provide an early breast cancer detection/warning technique that is simple, quick and 
may also be used for diagnosis of other types of cancers such as prostate cancer in men. 
The evidence indicates that screening mammography, when correctly performed at 
recommended intervals and combined with appropriate interventions, can reduce, but not 
eliminate, breast cancer mortality. This conclusion is based on evidence of efficacy in clinical 
trials and evidence of effectiveness in the general population. The “ideal” breast cancer 
screening tool has not yet been developed. All of the tests available for the screening and 
diagnosis of breast cancer have different strengths and limitations. The ideal test would 
combine the following characteristics:  
 The test should present a low risk of harm from screening  
 The test should have high degrees of specificity and sensitivity (low rates of false-
positive and false-negative results).  
 The test results should have uniform high quality and repeatability.  
 Interpretation of test results should be straightforward (objective).  
 The test should be simple to perform.  
 The test should be non-invasive.  
 The test should be able to detect breast cancer at a stage that is curable with available 
treatments.  
 The test should have the ability to distinguish life-threatening lesions from those that 
are not likely to progress.  
 The test should be cost-effective (usually considered <$50,000 per quality-adjusted life 
year saved).  
 The test should be widely available.  
 The test should be acceptable to women.  
Each modality has different strengths and limitations therefore it seems to be feasible to 
adopt a multi modality approach in order to achieve the optimum methodology for the 
detection and diagnosis of the breast tissue oncological abnormalities.  
1.1 Anatomy and physiology of female breast 
It is important to consider the physiology of the breast, as the changes seen in the breast 
during a woman’s life will have an effect on the properties of the tissues. The female breast 
is a complex and sensitive organ, which is composed of a mass of glandular, fatty, and 
fibrous tissues positioned over the pectoral muscles of the chest wall and attached to the 
chest wall by fibrous strands called Cooper’s ligaments (Figure 1). A layer of fatty tissue 
surrounds the breast glands and extends throughout the breast. The fatty tissue gives the 
breast a soft consistency. The glandular tissues of the breast house the lobules and the ducts.  
The female breast has a network of arteries and capillaries that carry oxygen- and nutrient-
rich blood to the breasts. The axillary artery extends from the armpit and supplies blood to 
the outer half of the breast. The internal mammary artery, which extends down from the 
neck, supplies blood to the inner part of the breast. The breast also contains lymph vessels. 
The lymphatic system is part of the immune system and is composed of blood vessels, 
lymph ducts and lymph nodes. Clusters of lymph nodes are located under the arm, above 
the collarbone, behind the breastbone and in various other parts of the body. 
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Fig. 1. The anatomical structure of the female breast 
The shape and appearance of female breast undergo a number of changes as a woman ages. 
In young women, the breast skin stretches and expands as the breasts grow, creating a 
rounded appearance. Young women tend to have denser breasts, due to the presence of 
more glandular tissue, than older women. The denser breasts lead to poorer contrast 
between healthy and diseased tissue in x-ray mammography. However the occurrence of 
breast cancer in younger women is low, with 80 % of breast cancers occurring in women 
over the age of 50. The growth of breast tissue is mainly influenced by the relative 
concentrations of progesterone and oestrogen in the body. During each menstrual cycle, 
breast tissue tends to swell due to variation in the oestrogen and progesterone levels. The 
milk glands and ducts enlarge resulting in retention of water by the breast. During 
menstruation, breasts may temporarily appear swollen and this can give rise to breast pain, 
tenderness, or they may feel lumpy. At menopause, a woman’s body stops producing 
oestrogen and progesterone, which causes a variety of symptoms in many women including 
hot flushes, night sweats, mood changes and vaginal dryness. During this period breasts 
also undergo many changes, such as mentioned earlier for the menstrual cycle, and 
sometimes appearance of cysts may be observed. The glandular tissue tends to shrink after 
menopause and is replaced with fatty tissue. The breasts also tend to increase in size and 
droop because the fibrous tissue loses its strength. The breasts become less dense after 
menopause, which makes the detection of breast cancer often easier in older women. A 
woman’s risk of breast cancer increases with age thus all women are recommended for 
breast cancer screening at regular interval beyond the age of 40. 
1.2 Main types of breast cancer 
Treatment of cancer depends on the type and stage of the cancer along with other issues 
such as the individual circumstances of the patient. Mostly breast cancer develops in the 
glandular tissue and is classified as adenocarcinoma, which is a cancer of the epithelium 
that originates in the glandular tissue. The common types of breast cancers are: 
Carcinoma in situ: This term is used for early stage cancer, when it is confined to the place 
where it started. In breast cancer, it means that the cancer is confined to the ducts or the 
lobules, depending on where it started. It has not gone into the fatty tissues in the breast nor 
spread to other organs in the body. 
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Ductal carcinoma in situ (DCIS): This is the most common type of non-invasive breast cancer. 
DCIS means that the cancer is confined to the ducts. It has not spread through the walls of 
the ducts into the fatty tissue of the breast. Over 70% of breast cancers are ductal 
carcinomas, which are associated with the milk ducts. Nearly all women with cancer at this 
stage can be cured.  
Infiltrating (invasive) ductal carcinoma (IDC): This type of cancer starts in a duct and breaks 
through the wall of the duct, and invades the fatty tissue of the breast (Figure 2), then 
spreading to other parts of the body. IDC is the most common type of breast cancer. It 
accounts for about 80% of invasive breast cancers.  
 
 
Fig. 2. Growth of ductal carcinoma 
Lobular carcinoma in situ (LCIS): This condition begins in the milk-making glands but does 
not go through the wall of the lobules. Although not a true cancer, having LCIS increases a 
woman's risk of getting cancer later. For this reason, it is important that women with LCIS 
follow the screening guidelines for breast cancer. 10% - 15% are lobular carcinomas 
associated with the lobes, and the rest are relatively rare forms of cancer such as of the 
connective tissue.  
Infiltrating (invasive) lobular carcinoma (ILC): This type of cancer starts in the lobules and can 
spread to other parts of the body (Figure 3). About 10% of invasive breast cancers are of this 
type. 
 
 
Fig. 3. Growth of lobular carcinoma 
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Benign conditions: There are many lesions and conditions that are non-cancerous but still 
affect the health of the breast and could be mistaken for cancer. These include 
fibroadenomas, cysts, mastalgia, breast calcifications, duct ectasia and periductal mastitis, 
fat necrosis, hyperplasia, intraductal papilloma, phyllodes tumour and sclerosing adenosis. 
2. Current breast cancer detection modalities and their limitations 
Breast is susceptible to a range of pathologic conditions. The most serious of these is breast 
cancer, which is widely recognised as the most common cancer in women. Other breast 
conditions include mastalgia, which is referred to a variety of conditions that cause breast 
pain, and benign lesions such as fibroadenomas and cysts. These conditions are not fatal but 
they are a source of undesirable symptoms and considerable anxiety for the patients. 
Improved methods for early detection and diagnosis of breast disease are essential to 
decrease mortality rates due to cancer. In addition a greater understanding of the 
physiology of the breast is needed to aid in the diagnosis of disease and in improving 
treatments. 
The breast cancer detection is a three part procedure. The first part is the identification of the 
abnormality in the breast tissue either by physical examination or by an imaging technique. 
Secondly the abnormality is diagnosed as a benign or malignant condition by using 
additional diagnostic methods or by biopsy and microscopic examination of the tissue 
morphology. The third part is concerned with biochemical characterisation of the malignant 
tissue in order to stage the cancer according to the size of the tumour and extent of invasion 
and metastasis. This then determines the prognosis and appropriate course of treatment. 
The most commonly used imaging modalities are described in the following sections.  
The main strategy of breast cancer detection is based on clinical examination and 
mammography. Mammography is considered to be the ‘gold standard’ test for breast cancer 
detection and diagnosis and is accepted as the most cost-effective imaging modality. The 
performance of a screening test is evaluated by three related measurements: sensitivity, 
specificity, and a positive predictive value. The sensitivity of a screening test is the 
proportion of people with the disease who test positive. Specificity is the proportion of 
people without the disease who test negative. The positive predictive value is the proportion 
of individuals with a positive screening test result who actually have the disease. In the 
development of optimum detection modality, there is often a trade-off between sensitivity 
and specificity, with an increase in one leading to a decrease in the other. The contribution 
of mammography continues to be challenged with persistent false-negative rates ranging up 
to 30%.The clinical examination has been challenged with reported sensitivity rates often 
below 65%. There is also variability in radiologists’ interpretation of mammograms with 
decreasing sensitivity in younger patients and those on oestrogen replacement therapy. In 
addition, recent data suggests that denser and less informative mammography images are 
precisely those associated with an increased cancer risk (Boyd et al, 1995). It has also been 
suggested that mammography procedure cannot be performed by an inexperienced 
technician or radiologist. With the current emphasis on earlier detection, there is now 
renewed interest in the development of complimentary imaging techniques that can also 
exploit the metabolic, immunological, and vascular changes associated with early tumour 
growth. While promising, techniques such as Doppler ultrasound and MRI are associated 
with a number of disadvantages, which include the following: 
 Duration of the test,  
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 Limited accessibility,  
 Need of intravenous access,  
 Patient discomfort,  
 Restricted imaging area,  
 Difficult interpretation  
 Limited availability of the technology  
These modalities are in fact more suited as the second-line options to pursue the already 
abnormal screening evaluations. This stepwise approach currently results in the non-
recognition, and thus delayed utilization of any second-line technology in approximately 
10% of established breast cancers (Moskowitz, 1995). This view is supported by another 
study of infrared screening of breast cancer [Keyserlignk & Ahlgren, 1998). A list of the 
established breast cancer detection modalities approved by FDA is given in Table 1.  
 
Modality Description 
Full-field digital 
mammography  
Detector responds to X-ray exposure, sends electronic 
signal to computer to be digitized and processed. 
Separates detector and image display. 
Computer-assisted detection  Computer programs to aid in identification of suspicious 
mammograms and classification as benign or malignant.  
Ultrasound : Compound 
imaging and Three-
dimensional ultrasound 
imaging 
Uses high-frequency sound waves to generate an image. 
Magnetic resonance imaging 
(MRI)  
Makes use of the property of nuclear magnetic resonance 
(NMR) to image nuclei of atoms inside the body. Image 
generated by signals from excitation of nuclear particles in 
a magnetic field. Breast tumours show increased uptake of 
contrast agent. 
Scintimammography  Image created with radioactive tracers, which concentrate 
more in cancer tissues than in normal tissues.  
Positron emission 
tomography (PET)  
Uses tracers such as labelled glucose to identify regions in 
the body with altered metabolic activity. 
Infrared Thermography  Measures heat emitted by the body. Tumours can raise 
skin surface temperature, which is detected by infrared 
cameras. Dynamic area telethermometry detects changes 
in blood flow. 
Electrical impedance imaging  Measures voltage at skin surface while passing small 
current through breast. Changes in cancerous tissue 
decrease impedance of tissue. 
Table 1. FDA approved modalities for breast cancer detection 
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2.1 X-ray mammography 
X-ray mammography is the most common method of imaging the breast at present. The 
technique involves the breast being compressed between two plates with an x-ray film 
placed underneath and low energy x-rays are then passed through the breast and the images 
are recorded. The best contrast between soft tissues is achieved at low energies and hence 
these are used in x-ray mammography. The x-rays are produced by an electron beam 
irradiating either a tungsten or molybdenum target depending on the size of the breast to be 
imaged. At low energies, the transmission is low causing a high dose to the patient. Thus a 
compromise between contrast and dose is necessary. This problem is reduced by 
compression of the breast. The breast is compressed to between 2 and 8 cm enabling a high 
contrast whilst keeping the dose within an acceptable level. Contrast is dependent on the 
thickness of the breast and the difference in linear attenuation coefficient (μ) between the 
tissue types. The value of μ is dependent on the atomic number of the material. Thus tissues 
with higher atomic numbers will produce a higher attenuation than others (e.g. 
microcalcifications). 
The established sensitivity of mammography is higher than 91% (Brem et al 2003), which is 
greater than any other imaging modality for breast cancer detection. This is the main reason 
for the use of mammography in screening programmes. The reported specificity of the 
technique is quite variable and is considered to be in the region of 72% (Bone et al 1997). 
This means that nearly a quarter of the benign lesions are diagnosed as suspicious, which 
leads to unnecessary invasive procedures, biopsies, in order to establish the true nature of 
the lesion. Furthermore, the sensitivity of mammography for younger women is lower than 
that for older women. Younger women have denser breasts and less adipose tissue. Adipose 
tissue provides a greater contrast to calcifications than denser fibrous tissue and so 
mammography is more successful in older women. 
Nearly one quarter of all invasive breast cancers are not detected by x-ray mammography in 
women aged between 40-49 years. However, the statistics for women above the age of 50 
years are significantly better (1 in 10). Treatment of women with undetected invasive 
cancers, because of false-negative results, may be delayed. Many mammographic 
abnormalities may not be cancer, but will prompt additional testing and anxiety. 
Approximately 10 percent of all screening mammograms are read as abnormal. This will 
result in additional diagnostic tests such as diagnostic mammography, ultrasound, needle 
aspiration, core biopsy, or surgical biopsy. Given the lower incidence of breast cancer in 40- 
to 49-year-old women compared with that in older women, false-positive examinations are 
more common in younger women and the proportion of true-positive examinations 
increases with increasing age. There is concern that women having abnormal 
mammograms, both true-positive and false-positive, experience psychosocial stresses, 
including anxiety, fear, and inconvenience. There is the concern that experiencing a false-
positive mammogram may affect subsequent willingness of the patient to undergo future 
screening mammography at ages when it is of greatest benefit. 
The main advantages of x-ray mammography are that the technique has good resolution 
and microcalcifications can easily be observed. Furthermore, the relatively fast imaging time 
allows many women to be scanned in one screening session. The major drawbacks of the 
modality are the use of ionising radiation, which is potentially harmful for the patient and 
the operator, and interpreting mammograms can be difficult due to differences in the 
appearance of the normal breast for each woman. The sensitivity is high (91.4% (Brem et al, 
2003) but is not 100% and also the specificity is relatively low for some types of tumours. 
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Particularly, the sensitivity is lower for women with dense breast tissue (e.g. younger 
women) and breast implants can affect the accuracy of mammography, as silicone implants 
are not transparent to X-rays. The disadvantages of compressing the breast are that it is, at 
best, uncomfortable and for many women with sensitive breasts it can be very painful. This 
limits the maximum time feasible for the imaging process. Also the spatial accuracy of the 
image can be distorted so that it is difficult to exactly locate an identified lesion.  
The risk of radiation-induced breast cancer has long been a concern and has driven the 
efforts to reduce the radiation dose per examination. Radiation has been shown to cause 
breast cancer in women, and the risk is proportional to the dose. Especially the younger 
women are at a greater risk for breast cancer due to the exposure to radiation. Radiation 
related breast cancers occur at least 10 years after exposure. However, breast cancer as a 
result of the radiation dose associated with mammography has not been established. 
Radiation from yearly mammograms during ages 40-49 has been estimated as possibly 
causing one additional breast cancer death per 10,000 women.  
2.2 Magnetic resonance imaging (MRI) 
The principal imaging modality used for the detection of breast tissue abnormalities is x-ray 
mammography, which has a high sensitivity, but suffers from a relatively poor specificity 
for some tumours and breast types, leading to unnecessary biopsies. Thus there is a need for 
an imaging technique that can non-invasively distinguish between malignant and benign 
lesions. At the present, magnetic resonance imaging (MRI) and ultrasound (US) can provide 
additional diagnostic information for this purpose.  
The theory of MRI is based on the fact that the nuclei of some atoms have a property known 
as spin. Such nuclei act like tiny current loops and consequently generate a magnetic field 
(or magnetic moment), along the spin axis. Under normal circumstances these moments 
have no fixed orientation so there is no overall magnetic field. When an external magnetic 
field is applied, the moments will align in certain directions. In the case of hydrogen nuclei, 
which are the most abundant nuclei in the human body, two discrete energy levels are 
created. An MRI detection system consists of a magnet, magnetic gradient coils, a radio 
frequency transmitter and receiver, and a computer that controls the acquisition of signals 
and computes the MR images obtained. When an atomic nucleus is exposed to a static 
magnetic field, it resonates when a varying electromagnetic field is applied at an 
appropriate frequency and an image is computed from the resonance signals. 
The signal in MRI arises from the rotating magnetisation, but it decays due to two different 
relaxation processes. The first process is the spin-lattice relaxation. The second relaxation 
process is the spin-spin relaxation. During spin-spin relaxation, the detected signal decays 
over a period of time. However, the spins are also subject to inhomogeneities in the 
magnetic field causing the signal to decay faster than the natural time period. Part of the 
signal can be obtained due to the spin-echo effect. This involves the application of a further 
RF pulse which causes the spins to be flipped by 180°. This means that the phase-position of 
each spin has been inverted and so nuclei that were precessing faster are now behind spins 
that were precessing at a slower rate. At the echo time TE, the spins will catch each other up 
and a peak in the signal will be detected. An MRI exam of the breast typically takes between 
30 and 60 minutes. Diffusion and perfusion MRI are relatively new procedures. Diffusion 
MRI measures the mobility of water protons whereas perfusion MRI measures the rate at 
which blood is delivered to tissue. Both of these factors vary in malignant tissues as 
compared with benign tissue and therefore can be used as indicators for cancer. 
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The injection of a contrast agent can enhance the ability of MRI to detect specific features or 
in the case of dynamic contrast-enhancement MRI the functionality of the tissue can be 
investigated. The contrast agents used are paramagnetic agents with gadolinium (Gd-
DTPA) being the most common. The increased vascularity of tumours produces a 
preferential uptake of contrast agent and the technique can be used to improve their contrast 
from surrounding normal tissue. In dynamic contrast-enhancement MRI, scans are 
repeatedly acquired following the contrast injection and the dynamic nature of contrast 
uptake can be examined, which may improve the differentiation of benign and malignant 
disease.  
The main advantages of MRI are that the modality is suitable for women with denser breasts 
and the technique is non-ionising. It is possible to take images in any orientation and 
determine multi-focal cancers. The technique can also show breast implants and ruptures. 
The disadvantages of MRI are that a contrast agent is required to provide adequate 
specificity and that it is immobile, expensive, and unsuitable for some women. The modality 
cannot image calcifications and can induce feelings of claustrophobia, and require long scan 
times in comparison to x-ray mammography. 
2.3 Ultrasound 
Ultrasound is defined as a frequency of sound above the threshold of human hearing (i.e. > 
20 kHz). The frequency range used in medical ultrasound imaging is 1 – 15 MHz. This 
allows wavelengths less than 1 mm to be measured and thus produces good spatial 
resolution. Ultrasound waves interact with tissue in a variety of ways but it is the reflection 
and transmission at interfaces between tissues of different acoustic impedance that is 
utilised in medical imaging. If there is a large acoustic mismatch between two tissues then a 
large fraction of the ultrasound intensity will be reflected. If there is a small difference in the 
acoustic impedance then most of the intensity will be transmitted. The time between pulse 
generation and the detection of an echo provides the depth of the reflecting interface, and 
thus images can be generated. Measuring the magnitude and time difference between 
different reflected signals can be used to determine the type, depth and size of different 
tissues. 
Ultrasound pulses are generated and detected by a hand-held transducer, based on an array 
of small piezoelectric crystals. The very low acoustic impedance of air means that any 
boundary between air and tissue results in a near 100% reflection, so to ensure that the 
ultrasound waves are coupled into the body an impedance matching gel is used between the 
breast and the transducer. As there is a large difference between the acoustic impedance of a 
liquid filled cyst and normal breast tissue, around 23% of the ultrasound wave is reflected at 
such a boundary, making this technique particularly useful for the diagnosis of such a 
lesion. The small differences in acoustic impedance between adipose tissue and glandular 
tissue mean that this technique is of particular use for younger women with denser breasts, 
where x-ray mammography is often unsuitable. Doppler ultrasound utilises Doppler shifts 
from Rayleigh backscattered ultrasound waves to determine the velocity at which red blood 
cells are moving. Doppler ultrasound can be used to monitor blood flow and as a result can 
be used as an indicator of vascularisation of a malignant tumour in the breast. 
Ultrasound is relatively inexpensive and a versatile technique. It can provide excellent 
contrast resolution, which means suspicious areas are easy to differentiate from normal 
tissue. X-ray mammograms are frequently followed up with ultrasound imaging to 
determine whether a lesion that appeared on a mammogram is a cyst or a solid mass. Since 
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a fluid-filled cyst has a different sound signature than a solid mass, radiologists can reliably 
use ultrasound to identify cysts, which are commonly found in breasts. The technique can 
be used for younger women and women with breast implants and is entirely safe, and can 
be used repeatedly. The main disadvantages of the modality are the lack of fine detail, 
difficulty in detection of microcalcifications, poor ability to see deep lesions and inability to 
differentiate between certain types of solid breast masses.  
2.4 Scintimammography 
Scintimammography or nuclear medicine imaging is sometimes used alongside x-ray 
mammography in the diagnosis of breast disease since this technique is able to determine if 
a located lesion is malignant. The technique involves injection of a radioactive tracer into the 
patient. The tracer emits radiation, which is detected using a gamma camera. Appropriate 
image reconstruction algorithms enable the distribution of the tracer within the body to be 
mapped. Since the tracer accumulates differently in malignant and benign tissues it can be 
used to distinguish between the two conditions. Several radioactive compounds have been 
investigated, although only one, technetium-99m sestamibi (MIBI), is approved by FDA for 
use in breast imaging. A nuclear medicine investigation of the breast usually takes between 
45 and 60 minutes. In a typical examination, the radioactive tracer (Tc-99m sestamibi) is 
injected into the patient’s arm. The patient lies face down on a special table with her breast 
suspended through a hole. The images of the breast are taken from several angles using a 
gamma camera. 
The advantages of scintimammography are that it can be used on patients with dense 
breasts and it can image large palpable lesions that do not appear with other imaging 
modalities. The modality involves the use of ionising substance that is injected into a patient 
(invasive) and is time consuming. Whilst it is 90% accurate for abnormalities over 1cm it is 
only 40- 60% accurate for smaller size abnormalities. The technique can be used to test tissue 
remaining from a mastectomy and can also be used to check for metastases in the auxiliary 
lymph nodes. 
3. Techniques under development for breast cancer detection 
There are several modalities that are at early stages of development but have a considerable 
potential as breast cancer detection devices. Majority of the imaging technologies for the 
breast are based on physical, mechanical, electrical, chemical and biological characteristics of 
the breast tissue. These detection techniques are based on their response to various tissue 
properties as listed in Table 2. 
In an article about controversy over breast cancer screening, Reidy argued that death from 
malignancy rather than detection of malignancy should be a point of reference in evaluating 
any screening modality, since fast growing tumours, although detected while small, may 
have already metastasised. As a result, the number of malignancy related deaths have not 
altered regardless of their detection stage (Reidy, 1988). This has led to the view that the 
development of any new breast cancer detection modality must recognise the existence of 
three biologically distinct breast cancer patient subgroups. Firstly, there is a group of 
patients, which have slow-growing population of malignant cells that show ability to 
metastasise until very late. The second group comprises of patients with rapidly growing 
tumours that can lead to the development of micrometastases long before the tumour is 
detectable using the current modalities. Finally, there is the group of patients that have 
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moderately fast growing tumours that may or may not be metastatic at the time of detection. 
The current breast cancer detection modalities are more valuable for the last group of 
patients. Some of the more likely modalities that can be developed as breast cancer 
diagnostic tools, which appear to be based on the recognition of the above points, are 
described in Table 3 and briefly discussed in the following sections.  
 
Mode of Imaging Tissue Property 
Physical Photon attenuation 
Temperature 
Electrical Conductivity 
Dielectric coefficient 
Impedance 
Mechanical Architecture 
Elasticity 
Biological Protein (expression/function) 
Perfusion 
Table 2. Properties of breast tissue exploited by different modes of imaging 
 
Modality Description 
Magnetic resonance 
spectroscopy  
Use of magnetic resonance spectra and “functional” molecular 
markers to measure biochemical components of cells and tissues. 
Optical imaging  Use of fibre-optic probes to obtain spectral measurements of 
elastically scattered light from tissue. Generates spectral signatures 
that reflect architectural changes at cellular and sub-cellular levels. 
Optical tomography Use of light to image the breast 
Electrical potential 
measurements  
Measurement of electrical potential at the skin surface. 
Proliferation of epithelial tissue disrupts normal polarization 
Electronic palpation  Quantitative palpation of breast using pressure sensors. 
Thermo acoustic 
computed 
tomography  
Breast is irradiated with radio waves, causing different thermal 
expansion of tissue and generating sound waves, from which a 
three-dimensional image is constructed. 
Microwave imaging Transmits low-power microwaves into tissue and collects 
backscattered energy to create three-dimensional image. Higher 
water content in malignant tissues causes more scatter 
Hall effect imaging  Induces vibrations by passing electric pulse through tissue while 
exposed to a magnetic field. 
Magneto 
mammography 
Tags cancerous tissue with magnetic agents that are imaged with 
SQUID magnetometers. 
Table 3. Modalities under development for breast cancer detection 
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3.1 Optical imaging 
Near infrared imaging is a simple method to determine the optical properties of tissues. It 
involves placing a light source onto the surface of the tissue and detecting the diffusely 
reflected light via a fibre/ detector placed some distance from the source. Measurements 
made in this manner can be used to determine the concentration of different chromophores 
such as oxy (HbO2) and de-oxy (Hb) haemoglobin within tissue. Optical imaging provides a 
potential alternative modality to the current breast cancer detection techniques. Diffuse 
optical tomography (DOT) and spectroscopy (DOS) are non-invasive techniques used to 
measure the optical properties of tissues. In the near-infrared (NIR) spectral window of 600 - 
1000 nm, photon propagation in tissues is dominated by scattering rather than absorption. 
Photons experience multiple scattering events as they propagate deeply into tissue (up to 10 
cm). The technique is based on the study of functional processes and provides several 
unique measurable parameters with potential to enhance breast tumour sensitivity and 
specificity. Optical tomography provides a distinction between different tissues based on 
their optical properties obtained from measurements of transmitted light. The presence of 
various substances in biological tissues contributes to the absorption of light. Tissue optical 
absorption coefficients provide access to blood dynamics, total haemoglobin concentration, 
blood oxygen saturation, water concentration and lipid content. These tissue properties are 
often substantially different in rapidly growing tumours; for example, high concentrations 
of haemoglobin with low oxygen saturation are suggestive of rapidly growing tumours due 
to their high metabolic demand. (Vaupel et al, 1991, 1998 & Weidner, et al 1992). The main 
substances of interest in optical imaging of breast tissue are water, lipids, haemoglobin and 
melanin. Of particular interest is the facility to exploit the differences between the 
absorption spectra of oxy-haemoglobin and deoxy-haemoglobin at near infrared 
wavelengths to produce images of blood volume and oxygen saturation (Cheng et al, 2003 & 
Jiang et al, 2003).  
Optical tomography involves transillumination of the breast using near infrared (NIR) light. 
Characteristic absorption by oxy- and deoxy- haemoglobin at NIR wavelengths can be 
exploited to yield oxygen saturation and blood volume information. This information can 
provide a distinction between the high vascularisation often associated with malignant 
lesions and benign or normal breast tissue. Cutler demonstrated the first use of light for 
breast imaging in 1929 (Cutler, 1929), but it was not until the mid 1980s that interest in the 
subject became widespread due to the emergence of new source and detector technologies 
(Hebden et al, 1997). The research activity in this field was further enhanced by the 
developments in computing technology, which allowed the use of algorithms to reconstruct 
images representing the optical properties contained within a three-dimensional volume. 
The constant improvement in processing speeds and detectors has made optical 
tomography a potential safe alternative imaging technique that, in combination with 
conventional imaging techniques, can provide greater specificity for breast cancer diagnosis.  
In a recent study, a 32 channel time-correlated single photon counting system has been 
utilised to perform the test (Yates, 2005). Specific data extracted from a histogram of the 
times of flight of photons across the breast is used to reconstruct images of the optical 
properties. The reconstruction is performed using a non-linear, finite element based 
algorithm. One system is based on two rings of different diameters to which source and 
detector bundles are attached. Images displaying heterogeneous features that are unique to 
specific healthy tissues and reproducible are presented. Pre-diagnosed benign lesions can be 
identified but they are not always the most dominant feature. A single tumour is identified 
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as a dominant increase in absorption. The second system based on a hemisphere filled with 
a coupling fluid can also be used. Preliminary findings suggest second method provides 
superior information to the ring system due to its three dimensional capability and its ability 
to provide consistent coupling. 
3.2 Electrical impedance based modalities 
Trans-scan (T-scan) and electrical impedance tomography (EIT) modalities are based on the 
principle that tissues have different conductivities depending on their cell structure and 
pathology. Cancerous tissue causes alterations in the intracellular and extracellular fluid 
compartments, cell membrane surface area, ionic permeability, and membrane associated 
water layers. These histological biochemical changes within the cancerous tissue give rise to 
measurable changes in tissue electrical impedance. When a small alternating current is 
placed across the breast, the increase in electrical conductance and capacitance of the cancer 
tissue distorts the electric field within the breast and the resulting impedance map can be 
used to highlight a malignant area. 
3.2.1 Trans-scan (T-scan) 
T-scan is an imaging technique that utilises the inherent differences in electrical impedance 
between neoplastic and normal tissue and maps noninvasively the distribution of the breast 
tissue electrical impedance and capacitance. It is a simple device that utilises measurements 
of electric impedance to distinguish between benign and malignant lesions. The 
methodology measures low-level bioelectric currents to produce real-time images of the 
electric impedance properties of the breast. It is considered that a T-scan used in addition to 
x-ray mammography can increase the specificity of breast cancer diagnosis. During a T-scan 
1.0 to 2.5 mA of AC electrical current are generated by the system and conducted through 
the body via a metallic wand held by the patient. The scanning probe is then moved over 
the breast, and the current at the surface is measured. This information is then used to 
construct an image, which is immediately displayed on a computer screen. A gel is used 
between the skin and the scanning probe to improve the conductivity. 
The technique employs relatively small and inexpensive devices and can detect small 
cancers down to 1 mm. The limitations of the method are that depth information is not 
available and microcalcifications cannot be detected. Furthermore T-scan cannot be used on 
patients with pacemakers and is less sensitive to larger tumours. The sensitivity and 
specificity of the T-scan have not yet been fully investigated, although values of 78% and 53 
% respectively have been reported (Tetlow & Hubbard, 2000). T-scan has also been 
evaluated for symptomatic patients and women with screen-detected abnormalities. 
Patients undergoing both mammographic and T-scan examinations, which subsequently 
underwent excision or core biopsy, were retrospectively analysed. The results suggested 
that the T-scan is a useful addition to the assessment of patients, increasing diagnostic 
accuracy in terms of both sensitivity and specificity (Barter & Hicks, 2000).  
3.2.2 Electrical impedance tomography (EIT) 
EIT uses the same principles as a T-scan but utilises a number of measurements obtained by 
applying different current distributions to reconstruct an image of the electric impedance of 
the whole breast. The quantities measured by EIT are related to the electric impedance at 
low frequencies via the Laplace equation. The solution of the Laplace equation is very 
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sensitive to noise in the measurements and so normalisation techniques are used. Most in-
vivo images use linear approximating techniques which attempt to find a solution for a 
small change in resistivity from a known starting value. Until recently, this change in 
resistivity was measured over time, and so EIT images displayed physiological function. 
More recently anatomical images have been produced using the same reconstruction 
technique, but by imaging changes with frequency (Osterman, et al, 2000).  
The advantages of using electric impedance devices are that they are much smaller and 
cheaper than other imaging modalities and use non-ionising radiation. Also in principle it is 
possible for EIT to produce thousands of images per second. Its main limitations are low 
resolution and large variation of images between subjects. The EIT technique still requires 
further research and development before it is approved for the detection of breast cancer. 
3.3 Modalities based on histological examination and biomarkers 
3.3.1 Fine needle biopsy 
If a breast lesion appears to be suspicious or is undefined following examination using the 
imaging methods described then the patient will undergo a biopsy. There are two degrees of 
biopsy: fine needle aspiration cytology and core biopsy. In the first biopsy technique a fine 
needle and syringe are used to obtain a small sample of cells from the suspicious area. If this 
sample is insufficient or the diagnosis remains inconclusive a core biopsy may be needed 
which requires a larger needle to remove a larger sample of cells. In both cases the 
procedure is painful and involves the extraction of potentially diseased tissue through 
healthy tissue. This is one of the main reasons for a considerable research activity for the 
development of non-invasive imaging techniques with greater specificity that can reduce the 
need for biopsy. 
3.3.2 Ductal lavage 
Ductal lavage is a relatively newer technique used to detect pre-cancerous and cancerous 
breast cell changes in women who are at high risk for developing breast cancer. It is 
estimated that over 95% of breast cancers begin in the cells lining the breast ducts. Ductal 
lavage involves analysing cells that have effectively been washed out from the breast ducts 
using a breast pump or aspirator. The cells are studied under a microscope to determine 
whether they have malignant characteristics before they develop into breast cancer. This 
technique is still in its early stages of development and is a similar idea to the Pap smear 
used to test for cervical cancer.  
3.3.3 Tumour markers  
These are substances produced by cancer cells and sometimes normal cells. They can be 
found in large amounts in the blood or urine of some patients with cancer. Less often, they 
can also be found in large amounts in the blood or urine of people who do not have cancer. 
There are many different kinds of tumour markers. Some are produced only by a single type 
of cancer. Others can be produced by several types of cancer. Most tumour markers used 
today are proteins or parts of proteins. They are detected by combining the patient's blood 
or urine with antibodies made to react with that specific protein. The results of any tumour 
marker test are considered with other laboratory test results and a thorough medical history 
and physical examination. The American Society of Clinical Oncology first published 
evidence-based clinical practice guidelines for the use of tumour markers in breast cancer in 
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1996, which are updated at regular intervals. Thirteen categories of breast tumour markers 
have been considered that showed evidence of clinical utility and were recommended for 
use in practice. These include: CA 15-3, CA 27.29, carcinoembryonic antigen, oestrogen 
receptor, progesterone receptor, human epidermal growth factor receptor 2, urokinase 
plasminogen activator, plasminogen activator inhibitor 1, and certain multiparameter gene 
expression assays. Not all applications for these markers were supported, however. The 
following categories demonstrated insufficient evidence to support routine use in clinical 
practice: DNA/ploidy by flow cytometry, p53, cathepsin D, cyclin E, proteomics, certain 
multiparameter assays, detection of bone marrow micrometastases, and circulating tumour 
cells (Harris et.al, 2007). However, as yet, there are no tumour markers that are useful for 
diagnosis of early stage breast cancer.  
3.4 Thermal imaging techniques (TITs) for breast cancer detection 
Thermography is based on the principle that metabolism and blood vessel proliferation in 
both pre-cancerous tissue and the area surrounding a developing breast cancer is almost 
always higher than in normal breast tissue. Developing tumours increase circulation to their 
cells by enlarging existing blood vessels and creating new ones in a process called 
neovascularisation or angiogenesis. This uncontrolled proliferation is considered to be of 
critical importance in the development of neoplastic condition. The tumour mass is unable 
to grow to a detectable size (2 mm3) without the establishment of a new blood supply, since 
passive diffusion of nutrients and waste products is not sufficient for the growing tumour’s 
metabolic requirements. Angiogenesis is induced as a result of the release of a variety of 
angiogenic peptides that may be produced by the neoplastic cells. These newly developed 
blood vessels are quite porous and provide easy access to the circulating immediately 
adjacent tumour cells. For this reason the propensity to metastasise has been related to the 
number of micro vessels found in a growing mass of tumour. (Nathanson et al, 2000; Wade 
& Kozolowski, 2007). This process frequently results in an increase in regional temperature 
of the breast and forms the basis of the thermal modalities for the detection of breast cancer. 
The first recorded use of thermo-biological diagnostics can be found in the writings of 
Hippocrates around 480 B.C. Mud slurry was spread over the patient and allowed to dry. 
The body areas that dried first were thought to indicate underlying organ pathology. Since 
then continued research and clinical observations proved that certain temperatures related 
to the human body were indeed indicative of normal and abnormal physiological processes. 
There are two thermal based modalities that could have a very significant impact on the 
detection and diagnosis of breast cancer. These are named as infrared thermography and 
microwave radiometry. Both techniques detect the changes in the physiology of the tissue 
rather than evaluating the changes in the tissue anatomical and dielectric features. Figure 4 
illustrates that the physiological changes (preclinical phase) in the tissue begin nearly eight 
years earlier before they become apparent in the form of mass of malignant tumour 
(Lundgren, 1981). 
Although thermography is an appealing method of screening for breast cancer, research 
over the past 20 years has failed to produce a system that is reliable for such a purpose and 
therefore thermography is not a widely used modality. However, it is expected that 
advances such as computerised thermal imaging will provide significant improvement in 
the cancer detection rate but this remains to be seen. Furthermore, attenuation of infrared 
radiation in tissue is high. For this reason thermography will only ever be able to provide 
information on the surface temperature variations and so no depth information is available. 
This is a severe limitation of infrared thermography in detecting breast cancer. 
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Fig. 4. Kinetics of tumour growth ((Lundgren, 1981) 
3.4.1 Infrared thermography 
Infrared thermal imaging has been used for several decades to monitor the temperature 
distribution over human skin. Abnormalities such as malignancies, inflammation, and 
infection cause localized increases in temperature that appear as hot spots or asymmetrical 
patterns in an infrared thermogram. Thermography, alternatively termed thermometry has 
been pursued for many years as a technique for breast cancer detection. Studies of 
thermography have focused on a range of potential uses, including diagnosis, prognosis, 
and risk indication and as an adjunct to existing technologies; however, the results have 
been inconsistent and scientific consensus has been difficult to achieve. The research activity 
in infrared thermography as cancer detection technique was diminished in the 1970s, but the 
recent technological advances have renewed the interest in the modality. Digital infrared 
cameras have much-improved spatial and thermal resolutions, and libraries of image 
processing routines are available to analyze images captured both statically and 
dynamically.  
As an addition to the breast health screening process, infrared imaging has a significant role 
to play. Due to the technique’s unique ability to image the metabolic aspects of the breast, 
very early warning signals have been observed in long-term studies. A breast tumour can 
raise the temperature of the skin surface by as much as 3 0C compared with the temperature 
of the skin surface of a woman with normal tissue probably due to the elevated rates of 
tumour metabolism and elevated levels of vascularity and perfusion. It is for this reason that 
an abnormal infrared image may be the single most important marker of high risk for the 
existence of or future development of breast cancer. Furthermore, the proven sensitivity, 
specificity, and prognostic value of the modality, makes infrared imaging one of the 
frontline methods for breast cancer screening. The diagnosis of cancer is based on the 
difference in temperature relative to that for the contralateral breast, which serves as a built-
in control. The procedure is non-invasive and does not require compression of the breast or 
radiation exposure.  
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3.4.2 Microwave radio thermometry (MRT) 
The National Cancer Institute (NCI) in the United States of America has funded numerous 
research projects to improve conventional and develop new technologies to detect, 
diagnose, and characterize breast cancer. According to the U.S. Institute of Medicine, an 
ideal breast screening tool is a low risk device that is sensitive to tumours, detects breast 
cancer at a curable stage, non-invasive, simple to use, cost effective and widely available. 
The device should also involve minimal discomfort to the user and provides easy to 
interpret, objective and consistent results. Of particular importance is the ability to clearly 
distinguish between malignant and benign tumours and early detection. A brief review of 
the published literature shows that all techniques have limited capability in these respects 
and surgery is required to establish the nature of the tumour. The research in this area is 
time consuming since the ultimate test of a technique beyond the proof of concept stage 
must be clinical trials. 
Microwave radio thermometry (MRT) is a modality that uses non ionising electromagnetic 
radiation for cancer detection in humans. The technique has attracted a great deal of 
research in the last three decades. An electromagnetic imaging method can be active or 
passive. In an active system, one or more antennas radiate onto the body, where the 
electromagnetic field is scattered by tissue dielectric inhomogeneities and then received by 
the same or other antennas. In multi-frequency active imaging, data is collected at various 
frequencies and for various locations of the antennas outside the body [Liu et al, 2002; 
Meaney et al, 2000]. Field data are known terms in the inverse scattering problem, whose 
solution attempts a retrieval of the contrast of an eventual dielectric anomaly with respect to 
the background permittivity of healthy tissues. On the other hand time-domain systems 
exploit higher frequencies and wide-band antennas showing some similarity to ground 
penetrating radar [Fear & Stuchly, 2000; Li et al, 2004].  
Thermal imaging methods include both infrared and microwave radiometry modalities. 
Both methods detect physiological tissue response, rather than evaluating anatomic 
dielectric features. Heat is released from the body on the whole electromagnetic spectrum 
with a maximum at infrared frequencies. There are several physiological features that are 
related to malignant tissue, which may contribute to the infrared signal. These include 
increased blood flow in the area surrounding a malignancy, angiogenesis, and the release of 
vasoactive mediators. The infrared imaging system uses a camera that is highly sensitive to 
infrared radiation in the appropriate spectrum. Microwave radiometry is based on the 
measurement of the electromagnetic field spontaneously emitted by a body in the 
microwave frequency range [Bardati & Solimini, 1983; Edrich, 1979; Leroy et al, 1998; Meyer 
et al, 1979]. Charged particles in motion are primary sources of incoherent thermal radiation 
propagating inside the body, where it is partially absorbed and partially radiated externally. 
Antennas located in the vicinity of the body collect and changes the radiation to an electrical 
current that fluctuates in the receiver's input unit. Assuming that the body is in a 
thermodynamic equilibrium, the spectral content of the radiometric signal can be related to 
the local temperature distribution in the body, allowing its retrieval to be attempted from 
radiometric data collected at different frequencies and for various antenna positions. A 
thermal anomaly may be a significant indicator of a malignancy. 
The fundamental basis for developing a microwave imaging technique for detecting breast 
cancer is the significant contrast in the dielectric properties, at microwave frequencies, of 
normal and malignant breast tissue, as evidenced by experimentally measured data [Li et al, 
2005; Bardati et al 2002]. The estimated malignant-to-normal breast tissue contrast is 
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between 2:1 and 10:1, depending on the density and water content of the different tissues. 
Therefore, microwave modality does not offer the potential for the high spatial resolution 
provided by X-rays, but it does permit exceptionally high contrast with respect to physical 
or physiological factors of clinical interest, such as water content, vascularisation or 
angiogenesis, blood-flow rate, and temperature. Microwave imaging techniques result in a 
three-dimensional (3-D) volumetric mapping of the relevant tissue properties, and thus offer 
in situ 3-D positioning of the tissue abnormalities. Furthermore, microwave attenuation in 
normal breast tissue is low enough to make signal propagation through even large breast 
volumes quite feasible (~ 4 cm). For these reasons, microwave breast imaging has the 
potential to overcome some of the limitations of conventional breast cancer screening 
modalities.  
Microwave systems in use or under development may be categorised into three types: 
passive, active or hybrid. However, the passive technique has been investigated for many 
years, with clinical trials undertaken with the availability of commercial units that are 
currently used mainly in conjunction with mammography. The passive method detects 
regions of increased temperature due to the tumour from the very small “natural” 
microwave signal from the breast (black body radiation as given by Planck’s law). The 
signals detected are very low and require sensitive electronic systems. Temperature 
differentials between adjacent areas on the breast are taken as an indication of an 
abnormality, using a similar area on the other breast as a reference – the approach is 
somewhat empirical. The increased tumour temperature is thought to arise from 
“vascularisation” (angiogenesis). There is a great deal of ongoing research, which is related 
to the development of thermal models of the breast to relate the measured temperature 
differentials with temperature rises located in the tissue. There is also a considerable focus 
for the last few years in the USA on the development of detecting antennas. There is 
evidence that the passive MRT technique can detect malignant tissue abnormality at an 
early stage, but as yet this cannot be taken as an established fact. 
Current understandings of the underlying pathological mechanisms for increased 
temperature in breast cancer are that breast cancer cells produce nitric oxide, which 
interferes with the normal neuronal (nervous system) control of breast tissue blood vessel 
flow by causing regional vasodilation in the early stages of cancerous cell growth, and 
enhancing angiogenesis in the later stages. The subsequent increased blood flow in the area 
causes a temperature increase relative to the normal breast temperature, and even deep 
breast lesions may also contribute to the detectable increase in the heat evolved. These 
changes relate to physiological breast processes. It is believed that in healthy individuals, 
temperature is generally symmetrical across the midline of the body. Subjective 
interpretation of many diagnostic imaging modalities, including microwave thermometry 
and infrared thermography, rely on the normal contralateral images are relatively 
symmetrical, and the likelihood that small asymmetries may indicate a tissue abnormalities. 
Therefore, in breast cancer, thermography/thermometry detects disease by identifying areas 
of asymmetric temperature distribution on the breast surface. 
Microwave radiometry is used for diagnosis of diseases by measuring small changes of 
internal tissue temperature. The detection and diagnosis is conducted by measuring the 
intensity of natural electromagnetic radiation of patient’s internal tissues at microwave 
frequencies. The intensity of radiation is proportional to the temperature of the tissues. 
Cancerous tumours have a significantly different index of refraction and the internal tissue 
temperature often changes due to inflammation changes in the blood supply or with 
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increased metabolism of cells during oncological transformation of tissues. Microwave 
radiometry measures the emission of natural radiation from the body in the microwave, or 
centrimetric, region of the electromagnetic spectrum. All materials above absolute zero emit 
natural, thermally generated electromagnetic radiation. At body temperature of 37°C the 
maximum intensity of radiation occurs in the infrared part of the spectrum at wavelengths 
close to 10 µmeters (Fraseri et al, 1987). 
Microwave thermometry may be envisioned as the microwave analogue of infrared 
thermography (Barrett, et al, 1980). Whereas infrared thermography uses wavelengths of 10 
mm (typical), microwave thermometry makes use of much longer wavelengths, typically 1 -
20 cm; this leads to important and fundamental differences between the two techniques as 
described in the literature(Barrett & Myers, 1975a, 1975b; Barrett et al, 1977, 1980). 
Microwave radiation is capable of penetrating human tissue and therefore the emission 
provides information related to subcutaneous conditions within the body. The intensity of 
microwave emission is linearly proportional to the temperature of the emitter. Therefore, 
microwave thermometry provides information related to internal body temperatures. The 
depth of penetration, and hence the depth from which microwave radiation may escape 
from the body, depends on the wavelength, the dielectric properties of the tissue and the 
water content of the tissue. Furthermore, the frequency used for microwave breast imaging 
needs to be low enough to provide adequate depth of penetration, but high enough to allow 
the use of small antenna array elements. The final resolution of the image depends on both 
the number of antenna array elements and the frequency. In general, resolution increases 
with frequency and the number of antenna array elements. In order to obtain useful images, 
there must be significant contrast between normal and malignant tissue and the greatest 
contrast in breast tissue occurs in the frequency range 600 MHz-1 GHz. 
The distinctive feature of microwave radiometry is an extremely low signal strength 
entering input of the antenna from the biological tissues. This signal strength is 
approximately 10-13 Watt. While conducting the measurement it is necessary to distinguish 
temperatures differing on a tenth part of degree, which corresponds to signal strength to be 
10-16 Watt. Therefore the special circuits are required for receipt, amplification and treatment 
of signals. So far, the application of microwave radiometry has been directed at the early 
detection and diagnosis of breast cancer. Present breast cancer detection techniques, other 
than radiometry, require that the tumour must have significant mass and contrast with 
respect to the surrounding tissue (i.e., palpation physical examination, mammography and 
ultrasound). This results in approximately 85 percent of all determinations of breast disease 
undergoing extensive surgical procedures. Early detection could lead to a more conservative 
treatment and a positive attitude toward detection. The diagnosis of breast cancer at a 
smaller size or earlier stage will allow a woman more choice in selecting among various 
treatment options.  
The passive MRT method is a non-invasive, non-ionizing procedure that determines the 
thermal activity of the tissue rather than mass and therefore when used in conjunction with 
one or more other detection modalities, could provide early indication of breast with good 
accuracy. The determination of thermal activity is a measurement of tumour activity, or 
growth rate, providing data beyond the physical parameters (i.e., size and depth determined 
by mammography). Suspicious results found by screening using microwave radiometry 
could then be referred for further investigation by mammography and other appropriate 
techniques. Medical microwave radiometry has a number of positive characteristics as 
follows:  
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 Early diagnosis of diseases;  
 Possibility of non-invasive detection of disease in internal organs before the appearance 
of structural changes that can be detected by X rays or ultrasound;  
 Completely harmless for the patients of all age and with any diseases as well as for 
medical staff;  
 Possibility to conduct the investigation repeatedly (control of treatment):  
 Depth of anomaly detection is from 3 to 10 cm;  
 Accuracy of measuring the internal averaged temperature ± 0,2 OC  
 Simplicity of the device handling, the procedure may be conducted by the secondary 
medical staff.  
 Time measuring of one point: 5 – 15 sec.  
3.5 The concept of the smart bra as an early warning system for breast cancer 
The concept of wearable early warning system for breast cancer is under investigation at the 
Institute of Materials Research and Innovation (IMRI), University of Bolton. The researchers 
are working on the development of a wearable system that integrates the passive microwave 
antennae with textile structures. The basic concept of this approach is to present the 
microwave antennas to the breast in the form of a ‘Smart Bra’. Work on developing antenna 
systems and microelectronics is being carried out. Miniaturisation of the radiometer, 
antennae and electronics and there integration with appropriate textile structures are the 
main thrusts of the research and development programmes in progress. It remains to be 
established how much of the electronics would be mounted on the bra and how critical 
accurate positioning of the sensors would be. The incorporation of the electronics is the 
critical part of the research and development programme. Work is also in progress on the 
development of wearable breast cancer device at De Montfort University, Leicester, UK. 
This is a low frequency active electrical impedance tomography (EIT) based system, which 
utilises the differences in electrical properties between healthy and malignant breast tissues 
and the researchers have introduced the concept of a “Smart Bra” which allows the 
impedance tomography to be carried out conveniently and rapidly. However, the 
microwave radio thermometry modality being adopted by the Bolton team is non-contact 
and passive whereas the EIT is an active modality albeit at low power levels. In the 
following sections the concept of MRT based wearable early warning system for breast 
cancer is described. 
The microwave radiometer is a device which measures the intensity of electromagnetic 
radiation from human body in microwave wave length. The noise power at the input of the 
microwave receiver is proportional to the internal temperature of human body. An array of 
receivers can resolve the local temperature inside the breast in 3-D and hence provide a 
signature of local temperature differences inside the breast. The geometrical resolution is 
determined by the element number and the bandwidth and frequency of operation. Tumour 
detection relies on temperature difference resolution, which is a function of the noise figure 
of the receiver, its stability and the bandwidth as well as the test integration time (Skou, 
2006).  
Traditional microwave radiometers for breast cancer detection known from literature and 
available on the market are rather large and heavy in weight. Today, only one relatively 
compact model of microwave radiometer (RTM-01-RES) is available in the market. The 
radiometer receives energy-emissions from the human body using an infrared sensor and a 
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microwave sensor. The weight of internal temperature sensor is rather high and 
consequently it is not possible to incorporate such a device in a self-powered wearable 
system. It is therefore necessary to design miniature balance zero Microwave Radiometer 
and the Microwave Multi-Channel Electron Switch (MMCES). Miniaturization is essential 
for both technical reasons, achieving direct coupling to antenna and good stability, as well 
as for integration into textiles for maximum comfort. In traditional microwave systems 
antennae are fabricated on rigid substrates, as wires or as hollow structures. Antennae on 
textiles have been demonstrated earlier but only with limited design variations, mainly as 
microstrip patch or slot antennae (Klemm et al, 2004, 2005; Locher, 2006; Klemm & Troester, 
2005, 2006; Behdad, 2004; & Alomainy et al, 2005). There is a need to explore different 
structures especially in view of multi-frequency or wideband operation.  
The relevant accuracy of measuring the noise power at the input of the receiver is ~ 10-3. The 
dielectric constant of a person may change dramatically from 5.5 for fat breast to 50 for 
muscle. Therefore, the reflection coefficient between antenna and human body tissue may 
change significantly and as a result about 10% of energy may be reflected from the antenna. 
However, the accuracy of noise power measurement should remain unchanged. In order to 
solve this problem it is necessary to use zero balance radiometer with compensation of 
reflections between antenna and human body tissue. This principle is used in most modern 
microwave radiometers (Leroy et al, 1998, Hand et al, 2001 & Lee et al, 2002). An overview 
of microwave radiometry is given in a recent publication (Hand et al, 2001). The balance 
multi-frequency microwave radiometer has also been described (Leroy et al, 1998). These 
researchers used 5 frequencies in calculating the temperature profile in the brain. It is very 
important to use multi-frequency radiometer in order to visualize the temperature inside 
body. But the increase in the number of frequencies increases the sizes and the weight of the 
radiometer and decreases the noise imperviousness of the device. The radiation from human 
body is very small therefore the noise immunity is one of the critical parameters of the 
microwave radiometer.  
It is expected that the multi frequency radiometer will have better accuracy for breast cancer 
detection in comparison with a single channel radiometer, but it is not evident that the 
sensitivity will increase greatly. Thousands of measurements during 10 years with the 
microwave radiometer (RTM-01-RES) have shown that there are about 10 % of breast cancer 
patients who have no skin temperature increase or brightness temperature increase (Burdina 
et al, 2005). Thus the probability that these patients will have temperature increase at 
another frequency is not very high. Due to the weight and sizes limitations for a wearable 
system, there is no reason to use more than two frequencies. Furthermore, skin temperature 
information is very important for breast cancer detection. 
The fluctuation error of radiometer is dependent on time of integration, the bandwidth and 
losses of the microwave part of the receiver. Usually for the receiver’s bandwidth of 500-600 
MHz the measurement time is 5 seconds and fluctuation error is 0.1°C. The increase of 
bandwidth may decrease the fluctuation error. Another possibility to decrease the 
fluctuation error is to increase the integration time. Monolithic microwave integrated circuit 
(MMIC) provides the opportunity to increase the bandwidth of microwave device greatly. 
Furthermore, for wearable, self-examination devices the time of measurement is not a very 
important factor, therefore, the fluctuation error may be minimized by choosing the proper 
value of integration time. 
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It may be possible to combine a single channel microwave radiometer and a MMCES. In this 
case, the results of brightness temperature measurement will highly depend on the 
environment temperature, due to the losses in the MMCES. To overcome this problem, it is 
necessary to use balance zero radiometer and balance the losses of MMCES and losses of 
reference noise source. In this situation the losses of MMCES do not decrease the 
performance of radiometer. Furthermore, it is possible to minimise the losses in MMCES by 
the utilization of integrated radiometer front-ends. The integration requires the design and 
fabrication of microwave monolithic integrated circuits with ultra low-noise performance. 
This can be achieved using state-of-the-art MMIC fabrication processes. Such components 
are very compact (few square millimetres) and therefore minimize losses and temperature 
variations. The employed fabrication processes can achieve amplifiers with noise figure 
below NF<0.5 dB with high gain resulting in excellent radiometer performance (Dabrowski 
et al, 2004). However, these devices are either large and operate at cryogenic temperatures 
or are relatively narrowband. There is a need to especially focus on the development of 
wideband for multi-frequency receiver in order to improve the overall system performance. 
Yet, another possibility is the introduction of multi-receiver system alleviating the need for 
an MMCES. This however requires identical channel operation, which can only be 
fabricated using identical components. In the development of MMIC for the radiometer 
front-end such a technique becomes feasible.  
Introduction of microelectronic microwave components close to the antenna requires 
appropriate textile integration technologies. This aspect has been dealt within various 
publications both with woven and nonwoven materials (Catrysse et al, 2004; Coosemans et 
al, 2005; Hermans et al, 2005; Van Langenhove et al, 2003a, 2003b; Scilingo et al, 2005 & 
Paradiso et al, 2005). However, only little data is available on the microwave properties of 
different woven and nonwoven materials (Locher, 2006). Interconnection to the microwave 
monolithic integrated circuit is an important area of research and development. One 
possible approach is the implementation of ribbon type interconnects, which can efficiently 
be used for power supply and low frequency output signals. The active components need to 
be developed with MMIC operating over a wide range. Low-noise amplifiers determine the 
overall noise performance of the receivers. Very wideband performance has been 
demonstrated in GaAs and CMOS technologies, respectively (Nosal, 2001; Jung et al, 2006; 
Xu et al, 2005 & Wang et al, 2005). However, in most cases a noise figure NF>1.0 dB over a 
frequency range of DC – 10 GHz has been achieved. There is a need to design amplifiers 
complying with the frequency range of DC – 10 GHz, but exhibiting a noise figure NF < 1.0 
dB with an associated gain of G > 30 dB. These parameters are well beyond the state-of-the-
art today. There is a need to develop MMIC components that can be used for the assembly 
of the microwave radiometer system. Figure 5 shows one possible functional scheme of 
Multi-Channel Microwave Radiometer. 
Multi-Channel Microwave Radiometer’s development consists of the following stages.  
 Designing of Multi-Channel switch.  
 Designing of Radiometer’s microwave parts 
 Designing of radiometer’s digital part and analog low-frequency part of feedback 
circuit. 
 Software design for visualization of the measurements and for the radiometer’s 
microcontrollers. 
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Microwave radiometer consists of an electronic switch, circulator, isolator, low-noise 
amplifier, filter, amplitude detector and miniature reference noise source with the 
temperature sensor. All of these components parts must be designed in miniature sizes 
using MMIC and plastic materials. 
There are two critical parameters which define Radiometer’s quality: 
 
 
Fig. 5. The functional scheme of Multi-Channel Microwave Radiometer 
1. Brightness temperature error when the reflection’s coefficient of antenna changes. 
2. Brightness temperature error when the environment’s temperature changes. 
The over arching aim of the research in progress on the development of wearable breast 
cancer detection system is to deliver a miniaturized microwave technology, Multi-frequency 
Microwave Radiometry (MFMWR), which is a totally non-invasive and passive method for 
cancer detection. It is proposed to use microwave radiometry (MWR) to detect the “hot 
spots” (the cancerous regions) in the breast tissue. This technology was initially used in the 
field of astrophysics, measuring the minute amounts of microwave energy emitted by stars 
and planets. The same principle can be used for medical diagnostics (Chaudhary, 1984), as 
anything that can absorb radiation also emits radiation. In MWR, the power in the 
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microwave region of the natural thermal radiation from body tissues is measured to obtain 
the brightness temperature of the tissue under observation. The brightness temperature at 
an antenna centre frequency fi is, 
 
,
, , ,
(1 )
(1 )
i tissue ii
B i i B tissue i
i i
R PP
T R T
k df k df
       (1) 
Where Ptissue,i is the thermal radiation power emitted by the tissue, Pi is the power received 
by the antenna in a bandwidth dfi around fi, Ri is the power reflection coefficient at the skin-
antenna interface at fi and k is Boltzmann's constant.  
According to the Rayleigh-Jeans law, at microwave frequency fi, the thermal radiation 
intensity is proportional to the absolute temperature, so that 
 , ( )B i iT W T r dv

   (2) 
where T(r) is the absolute temperature in a tissue volume of dv located at r, Wi(r) is the 
receiving antenna’s weighting function and the integration is over the antenna's field of 
view Ω.  
It can be seen that (equation 1) that the brightness temperature ,B iT is dependent upon the 
temperature in the tissue , ,B tissue iT  and the reflection coefficient R. For balance zero 
radiometer with the compensation of the reflection on the border antenna and tissue the 
reflection from the tissue is compensated by thermal radiation of the radiometer and the 
brightness temperature is independent of reflection coefficient R. Therefore, for non-
invasive detection of temperature abnormalities it is possible measure the power radiation P 
from the tissue. 
Thus the measured brightness temperature at frequency fi,  
 ,
( )
1
i
B i
i
W T r dv
T
R
 

 (3) 
The receiving antenna's weighting function depends upon its operating frequency and 
microwave attenuating properties of the tissues, as well as antenna characteristics. Microwave 
reflections occur at interfaces between different tissue regions and between these regions and 
the measuring equipment. Since the attenuation of microwaves in tissue and the antenna 
characteristics are frequency dependent, the temperature-depth profile within the tissue 
beneath the antenna can be found using a multi-frequency radiometer and a stable solution to 
the inverse problem of retrieving the temperature-depth dependence from a set of measured 
brightness temperatures. The human body’s tissues have different permittivities therefore the 
reflection coefficient of the antenna for diverse people or in different tissues can reach 10%. 
This fact can decrease noise power at the input on the radiometer. But brightness temperature 
cannot change in spite of the fact that the brightness temperature is proportional to noise 
power at the input on the radiometer. This problem can be overcome by balance zero 
radiometer with sliding scheme of the reflections compensation.  
Evidently the temperature of microwave part of the radiometer may change greatly. This 
leads to noise power change at the input of the radiometer. If the front-end loss of 
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radiometer is about 1 dB, one degree change in the environment temperature will lead to 
brightness temperature change in 0.4 degree. This is why the radiometer input circuits 
temperature is usually stabilized. But this is not feasible for the wearable self-powered 
detection system because of the power demand. For balanced radiometer it is possible to 
optimize parameters of input circuit including Multi-Channel Switch and the reference noise 
source circuit to minimize error due to environment temperature changes. However, if the 
losses of microwave part of radiometer do not change in time, the error due to environment 
temperature change can be compensated. For this purpose it is necessary to measure the front-
end temperature. This principle was successfully used in industrial single-channel radiometer 
(RTM-01-RES) and can be applied to the multi-channel radiometer. For this purpose it is 
important to measure antenna array temperature and to transmit this information to the 
radiometer. Software is a need for visualisation of the results of the measurements and the 
database storage in the control centre. It is vital that radiometer should monitor the function of 
its various components appropriately, estimate the measurement error and transmit this 
information to the central database by wireless connection. This allows the estimation of the 
radiometer’s accuracy automatically. Fabrication of the breast cancer microwave screening 
system also requires the development of the hardware for the system.  
Microwave thermometry is the detection of microwave radiation from the human body and 
may be considered as the microwave equivalent of infrared thermography. Infrared 
thermography typically uses wavelengths of 10 µmetre, whereas in microwave thermometry 
much longer wavelengths are employed (1 -20 cm). The other major differences between the 
two modalities can be summarised as following: 
 Microwave radiation is capable of penetrating human tissue and therefore the 
emissions can provide useful thermal signals related to the subcutaneous conditions 
within the body. On the other hand, infrared radiation is not able to penetrate such 
depths and therefore is able to detect conditions close to the surface i.e. skin. 
 The intensity of microwave emission is linearly proportional to the temperature of the 
emitter. Therefore a measurement of the emission may be easily related to the 
temperature of the emitter. Infrared intensity measurements may also be related to the 
body temperature but this relationship is somewhat nonlinear. 
 Microwave emission gives coarser spatial resolution (~ 1cm) than infrared because of its 
longer wavelength than infrared (~1mm). This supposes that microwave thermography 
provides information about internal body temperatures. The depth of penetration, and 
hence the depth from which microwave radiation may escape from the body, depends 
on the wavelength, the dielectric properties of the tissue, and, most importantly, on the 
water content of the tissue.  
Development of a wearable, self-powered early warning system for breast cancer will also 
require the production of textile structures that are flexible, comfortable, breathable, light and 
suitable for integration with the materials developed to perform various functions to operate 
the cancer detecting devices produced. Conducting fibres and filaments are needed to produce 
fabrics using a range of mechanical conversion methods, particularly knitting, crochet or 
braiding to produce the developmental materials. The structures then need to be characterised 
and optimised. Conducting fabrics can also be prepared using chemical methods, including 
coating, printing and lamination. Wet chemical methods and dry methods can be employed 
for this purpose. The integrated textile structures must be tested for their efficiency, durability, 
launderability, mechanical and comfort properties. Finally, the integrated textiles need to be 
converted into wearable structures to act as cancer detection devices. 
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4. Conclusions 
At present x-ray mammography is the most commonly used breast imaging technique and is 
the only modality used for routine screening. X-ray mammography has become the “gold 
standard” for breast imaging. The technique has a high sensitivity and is able to detect very 
small tumours and calcifications. The main limitations of x-ray mammography are that it has a 
poor specificity for some tumour types and that it is unsuitable for use on women with dense 
breasts. In addition, x-ray mammography uses ionising radiation and usually causes 
considerable discomfort to the patient. Thus there is potential for an alternative technique to 
replace x-ray mammography or to be used as an additional resource to improve the overall 
specificity of the diagnosis. As discussed MRI, ultrasound and Nuclear medicine are currently 
used to provide additional diagnostic information, but all have their limitations and are not 
alternatives to mammography. Other techniques are currently being investigated such as EIT 
and infrared thermography but as yet these have severe limitations in resolution and 
specificity. Thus there still remains a niche for an additional imaging modality to aid in the 
early detection and diagnosis of breast tissue oncological abnormalities. 
Microwave radiometry (MRT) appears to be an attractive alternative modality for breast 
imaging. MRT can be used effectively in breast cancer investigation. The method has many 
advantages over the currently used breast cancer detection techniques: 
 Oncological changes in tissues could be detected earlier using MRT as compared to the 
classical methods based on ultrasounds and ionising radiation 
 Breast cancer detection is made at a curable stage 
 The technique is non-invasive and non-hazardous both to the patient and the device 
operator. 
 MRT is easy to use, cheap and fast 
 Involves no risk for patients of any age 
 Involves a minimum discomfort for patient, easily accepted by women - is easy to 
interpret and objective. 
The MRT can be used repeatedly to improve cancer detection rates and monitor the progress 
of cancer treatment. Using microwave radiometry in conjunction with other traditional 
modalities can significantly improve the diagnosis, especially for the patients with fast 
growing tumours. Studies show that breast thermometry has the ability to warn a woman 
that a cancer may be forming many years before any other test can detect the condition. The 
major gaps in knowledge can be addressed by more robust research on the technologically 
advanced microwave thermometry devices and large-scale, prospective randomised trials 
for population screening and diagnostic testing of breast cancer. The MRT system 
components can be miniaturised and integrated with textiles to produce wearable early 
warning systems for breast cancer.  
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The book "Advances in Cancer Therapy" is a new addition to the Intech collection of books and aims at
providing scientists and clinicians with a comprehensive overview of the state of current knowledge and latest
research findings in the area of cancer therapy. For this purpose research articles, clinical investigations and
review papers that are thought to improve the readers' understanding of cancer therapy developments and/or
to keep them up to date with the most recent advances in this field have been included in this book. With
cancer being one of the most serious diseases of our times, I am confident that this book will meet the
patients', physicians' and researchers' needs.
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